alexa Hou Shengtao | South University of Science and Technolo

Archives of Science
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Hou Shengtao

Hou Shengtao Hou Shengtao
Department of International Cooperation
South University of Science and Technology
Brain Science Research Center
P.R.China
Tel: +0755-88018418
Biography

Amongst many important discoveries, his team was the first to demonstrate that axon guidance molecules exacerbate brain function recovery after stroke through inducing axon shortening and active neuronal death. His team was also responsible for the seminal work showing that transcription factor E2F1 mediates the death of postmitotic neurons and that E2F1 regulates neuronal death in stroke brain. These studies revealed novel targets for the development of new drugs to promote brain function recovery. He published a series of high impact reports on molecular mechanisms of neuronal death (J Clin Invest, J Neurosci, JBC, Mol Cell Biol,) which were widely cited by other research groups. His team also made technological advancement in successfully constructing several hypoxia-inducible, neuron-specific adenoviral expression vectors, which have potential important clinical applications. The long-term goal of his research is aimed at reducing stroke-induced brain damage and speeding up recovery process through new scientific discoveries and technological innovations. The impact of his work is to reduce socio-economical burden to the society due to stroke-induced incapacity of brain function. Born in 1963, Professor Hou received his doctoral degree from the Faculty of Medicine, University of Glasgow in 1991. His doctoral study was supported by a full University of Glasgow Graduate Scholarship and a prestigious Overseas Research Student Award from the UK. After successfully completing his postdoctoral training at the Institute of Psychiatry, King’s College London, University of London (1991-1993),and the Department of Biochemistry, University of Bristol (1993-1996), Dr Hou was recruited by the National Research Council of Canada as Assistant Research Officer in May 1996. Since then, Dr Hou has risen to the rank of Group leader, Senior Research Officer (tenured position) and Adjunct Professor at the Department of Biochemistry, Immunology and Microbiology of the University of Ottawa to train doctoral and postdoctoral students. Dr Hou received many awards and research grants from research organizations of Canada, UK, and China. He was Principal Investigator and Project Leader of several Canadian National Research projects, a Canada-China Joint Health Initiative project and two Canada-British Council Joint Research Projects.

Research Interest

Professor Hou’s research is focused on identifying novel molecular targets in the complex cascade of post stroke events and developing novel experimental strategies and drugs relevant to clinical therapeutics. Strategies to promote regenerative axonal outgrowth in the CNS after brain injury are thwarted by the plethora of inhibitory ligands and the ligand promiscuity of some of their receptors secreted from oligodendrocytes/myelin, reactive astrocytes and fibroblasts in the scar tissue. Neurons must integrate this multitude of inhibitory molecular cues, generated as a result of cortical damage, into a functional response. More often than not the response is one of growth cone collapse, axonal retraction and neuronal death. Deciphering the precise molecular and biochemical mediators modulating retraction and collapse of the axonal network during neuronal death following cerebral ischemia represents an enormous potential for rational development of strategies for neuroprotection and regeneration. His team employs genomics, proteomics, pharmacology and convergence technologies, such as mass spectrometry based imaging of brain peptides and lipids, to investigate fundamental mechanisms of neuroprotection and recovery after stroke. Based on these mechanistic studies novel approaches are being developed to protect the brain and to stimulate brain repair following stroke.

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords